Reports Q3 revenue $604.69M, consensus $600.62M. “It was an excellent quarter for Ryan Specialty (RYAN) by all measures,” said Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty. “We grew total revenue 20.5% led by 11.8% organic revenue growth. We expanded Adjusted EBITDAC margin by 220 basis points year-over-year while growing Adjusted EPS by 28%. Along with our strong results, we continued to execute our M&A strategy by closing five acquisitions through the beginning of October. In addition, our leadership transition has been seamless, and we are thrilled to have Tim Turner as our new CEO. I am confident that we have the right team in place to advance our winning strategy today and over the long term.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target raised to $84 from $75 at BofA
- BMO upgrades Ryan Specialty to Outperform on EBITDA growth runway
- Ryan Specialty upgraded to Outperform from Market Perform at BMO Capital
- Ryan Specialty Group Plans Debt Refinancing and Offering
- Ryan Specialty initiated with an Overweight at Barclays